These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19874252)

  • 1. Terbinafine: a pharmacological and clinical review.
    Krishnan-Natesan S
    Expert Opin Pharmacother; 2009 Nov; 10(16):2723-33. PubMed ID: 19874252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
    Pérez A
    Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole and terbinafine in perspective. From petri dish to patient.
    De Doncker P; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of terbinafine against serious fungal pathogens.
    Ryder NS
    Mycoses; 1999; 42 Suppl 2():115-9. PubMed ID: 10865917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antifungal agents in pediatric practice.
    Das S; Shivaprakash MR; Chakrabarti A
    Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
    Chamilos G; Kontoyiannis DP
    Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of terbinafine in rare and refractory mycoses.
    Revankar SG; Nailor MD; Sobel JD
    Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
    Schmid-Wendtner MH; Korting HC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
    Meerpoel L; Backx LJ; Van der Veken LJ; Heeres J; Corens D; De Groot A; Odds FC; Van Gerven F; Woestenborghs FA; Van Breda A; Oris M; van Dorsselaer P; Willemsens GH; Vermuyten KJ; Marichal PJ; Vanden Bossche HF; Ausma J; Borgers M
    J Med Chem; 2005 Mar; 48(6):2184-93. PubMed ID: 15771461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing?
    Vazquez JA
    Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.
    Gupta AK; Ryder JE; Lynch LE; Tavakkol A
    J Drugs Dermatol; 2005; 4(3):302-8. PubMed ID: 15898285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.